WHO ICTRP trial
Determining the effect of topical Gabapentin ointment on neuropathic pain.
IRCT20241207063969N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20241207063969N1 |
|---|---|
| Public title | Determining the effect of topical Gabapentin ointment on neuropathic pain. |
| Scientific title | Investigating the effect of topical Gabapentin ointment on peripheral neuropathic pain in cancer patients treated with Oxaliplatin. |
| Primary sponsor | Sabzevar University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Neuropathic pains caused by cancer. Other specified diabetes mellitus with diabetic neuropathic arthropathy;E13.610 |
| Interventions | Intervention 1: Intervention group: Patients in this group will apply 10% gabapentin gel as a base cream (liposomal) to the pain site. They will be asked to clean the painful area and then massage 4 ml of the cream onto the area of… |
| Registration date | Mar 26, 2025 |
| Target size | 116 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: